Cited by 152Dementia and Cognitive Impairment ResearchDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Fasting insulin and incident dementia in an elderly population of Japanese-American men

Peila, Rita, Rodriguez, Beatriz L., White, Lon R., Launer, Lenore J.·2004·Neurology

DOI 10.1212/01.wnl.0000129989.28404.9b

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To evaluate the association of fasting insulin level to incident dementia in a cohort of elderly men. METHODS: Data are from the Honolulu-Asia Aging Study, a community-based study of Japanese-American men, aged 71 to 91 years in 1991. Serum insulin was measured in 1991 and participants were grouped based on their insulin levels. Dementia was ascertained in 1991, 1994, and 1996 according to international guidelines. The 2,568 men dementia-free in 1991 were reexamined in 1994 and 1996; 244 new cases of dementia were diagnosed. Survival analysis with age as the time scale was used to estimate the risk (hazard ratio [HR] and 95% CI) for incident dementia associated with levels of insulin. RESULTS: The risk of dementia was increased at the two extremes of the insulin distribution (lower and upper 15th percentiles). Compared to the rest of the cohort subjects in the lowest 15th percentile and highest 15th percentile had an increased risk for dementia (HR = 1.54, CI 1.11 to 2.11 and HR = 1.54, CI 1.05 to 2.26). In men with insulin levels <22.2 mIU/L the risk for dementia decreased with increased levels of insulin (HR = 0.76, CI 0.72 to 0.79 for each increase of one logarithmic unit -2.72 mIU/L of insulin). In men with insulin levels >/=22.2 mIU/L the risk for dementia increased with increasing levels of insulin (HR = 1.64, CI = 1.07 to 2.52 for each 2.72 mIU/L). CONCLUSIONS: Both low and high levels of insulin are associated with an increased risk of developing dementia.

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000129989.28404.9b

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Generalized Linear Models
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia
Teng, E. L., Hasegawa, K., Homma, A., Imai, Y., Larson, E., Graves, A., Sugimoto, K., Yamaguchi, T., Sasaki, H., Chiu, D., et al. (1994) · International Psychogeriatrics · doi:10.1017/s1041610294001602 · Cited by 926
Self-citation
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808
How good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype
Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560

Show all 45 references

Research works printed but not linked: 3

Graves AB Larson EB Kukull WA White LR Teng EL. Screening for dementia in the community in cross-national studies: comparison between the Cognitive Abilities Screening Instrument and the Mini-Mental State Examination. In: Corain B Iqbal K Nicolini M Winbald B Wisniewski H Zatta P ed. Alzheimer’s disease: advances in clinical and basic research. New York NY: John Wiley & Sons 1993; 113–119.
Cleveland WS. Visualizing data 1st ed. New Jersey: Hobart Press 1993.
10.1212/01.WNL.0000065916.25128.25 · DOI

Sorted by citations

Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 578
Estrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study
Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eee25f · Cited by 432
Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C. A., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., & Panza, F. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.007 · Cited by 365
A life-course approach to the aetiology of late-onset dementias
Whalley, L. J., Dick, F. D., & McNeill, G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70286-6 · Cited by 358
Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4f6 · Cited by 328
Impairment of the glymphatic system after diabetes
Jiang, Q., Zhang, L., Ding, G., Davoodi-Bojd, E., Li, Q., Li, L., Sadry, N., Nedergaard, M., Chopp, M., & Zhang, Z. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654702 · Cited by 308
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
Li, X., Leng, S. X., & Song, D. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s74042 · Cited by 314
Aerobic Exercise Improves Cognition for Older Adults with Glucose Intolerance, A Risk Factor for Alzheimer's Disease
Baker, L. D., Frank, L. L., Foster‐Schubert, K. E., Green, P. S., Wilkinson, C. W., McTiernan, A., Cholerton, B., Plymate, S. R., Fishel, M. A., Watson, G. S., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100768 · Cited by 309
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
Luchsinger, J. A., Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., & Bagiella, E. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150493 · Cited by 285
“The rationale for this stratification was that observational studies have shown that APOE-ε4 genotype modifies the association of hyperinsulinemia and diabetes with AD (risk is much higher in those with APOE-ε4)[27-29] and a pilot randomized trial of the insulin sensitizer rosiglitazone reported that this medication w…”
Mid- and Late-Life Diabetes in Relation to the Risk of Dementia
Xu, W., Qiu, C., Gatz, M., Pedersen, N. L., Johansson, B., & Fratiglioni, L. (2009) · Diabetes · doi:10.2337/db08-0586 · Cited by 284
Early-Life Risk Factors for Alzheimer Disease
Borenstein, A. R., Copenhaver, C. I., & Mortimer, J. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201854.62116.d7 · Cited by 260
Diabetes and Risk of Parkinson’s Disease
Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., & Pezzoli, G. (2011) · Diabetes Care · doi:10.2337/dc11-1584 · Cited by 247
Impaired insulin secretion increases the risk of Alzheimer disease
Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240
Cardiovascular risk factors and dementia
Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.06.004 · Cited by 225
Measures of Adiposity and Dementia Risk in Elderly Persons
Luchsinger, J. A., Patel, B. N., Tang, M., Schupf, N., & Mayeux, R. P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.392 · Cited by 237
The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease
Xu, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Diabetes · doi:10.2337/db06-0879 · Cited by 221
Adiposity, Type 2 Diabetes, and Alzheimer's Disease
Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 221
The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study
Rawlings, A. M., Sharrett, A. R., Albert, M., Coresh, J., Windham, B. G., Power, M. C., Knopman, D. S., Walker, K. A., Burgard, S. L., Mosley, T. H., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0120 · Cited by 222
Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?
Stanley, M., Macauley, S. L., & Holtzman, D. M. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160493 · Cited by 201
Encephalopathies: the emerging diabetic complications
Sima, A. A. F. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0218-0 · Cited by 189
Hyperinsulinemia and Cognitive Decline in a Middle-Aged Cohort
Young, S. E., Mainous, A. G., & Carnemolla, M. (2006) · Diabetes Care · doi:10.2337/dc06-0915 · Cited by 180
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease
Luchsinger, J. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.048 · Cited by 171
Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
Wilcox, K. C., Lacor, P. N., Pitt, J. E., & Klein, W. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9691-4 · Cited by 159
Obesity and Lowered Cognitive Performance in a Canadian First Nations Population
Salerno, J., Bruce, S. G., Lou, W. Y. W., Hanley, A. J., Greenwood, C. E., & Young, T. K. (2009) · Obesity · doi:10.1038/oby.2009.161 · Cited by 143
Vascular Risk Factors: Imaging and Neuropathologic Correlates
Knopman, D. S., & Roberts, R. O. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091555 · Cited by 123
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lü, L., Fu, D.-L., Li, H., Liu, A., Li, J.-H., & Zheng, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085781 · Cited by 122
Peripheral insulin and brain structure in early Alzheimer disease
Burns, J. M., Donnelly, J. E., Anderson, H. S., Mayo, M. S., Spencer-Gardner, L. S., Thomas, G., Cronk, B. B., Haddad, Z., Klima, D., Hansen, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000276952.91704.af · Cited by 120
Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort
Knopman, D. S., Mosley, T. H., Catellier, D., & Sharrett, A. R. (2005) · Neurology · doi:10.1212/01.wnl.0000176074.09733.a8 · Cited by 115
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease
Carlsson, C. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100012 · Cited by 109
Amyloid Precursor Protein Expression Is Upregulated in Adipocytes in Obesity
Lee, Y., Tharp, W. G., Maple, R. L., Nair, S., Permana, P. A., & Pratley, R. E. (2008) · Obesity · doi:10.1038/oby.2008.267 · Cited by 104
Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 101
Neurodegeneration in Diabetes Mellitus
Umegaki, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_19 · Cited by 94
Type 2 diabetes, related conditions, in relation and dementia: An opportunity for prevention?
Luchsinger, J. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091687 · Cited by 91
Exercise or physical activity and cognitive function in adults with type 2 diabetes, insulin resistance or impaired glucose tolerance: a systematic review
Zhao, R. R., O’Sullivan, A. J., & Fiatarone Singh, M. A. (2018) · European Review of Aging and Physical Activity · doi:10.1186/s11556-018-0190-1 · Cited by 88
Obesity, Insulin Resistance, and Alzheimer's Disease
Hildreth, K. L., Van Pelt, R. E., & Schwartz, R. S. (2012) · Obesity · doi:10.1038/oby.2012.19 · Cited by 86
Diabetes, related conditions, and dementia
Luchsinger, J. A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.063 · Cited by 88
Diabetes and brain aging: Epidemiologic evidence
Launer, L. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0069-1 · Cited by 87
Self-citation
Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes
Hayashi, K., Kurioka, S., Yamaguchi, T., Morita, M., Kanazawa, I., Takase, H., Wada, A., Kitagaki, H., Nagai, A., Bokura, H., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.002 · Cited by 82
Ginsenoside Rg1 Decreases Aβ1–42 Level by Upregulating PPARγ and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease
Quan, Q.-K., Wang, J., Li, X., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059155 · Cited by 77
Metabolic Syndrome and Cognitive Decline in Early Alzheimer's Disease and Healthy Older Adults
Watts, A. S., Loskutova, N., Burns, J. M., & Johnson, D. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121168 · Cited by 72
Cognitive dysfunction: An emerging concept of a new diabetic complication in the elderly
Umegaki, H., Hayashi, T., Nomura, H., Yanagawa, M., Nonogaki, Z., Nakshima, H., & Kuzuya, M. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2012.00922.x · Cited by 75
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
Burns, J. M., Honea, R. A., Vidoni, E. D., Hutfles, L. J., Brooks, W. M., & Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.011 · Cited by 74
Adiposity and Alzheimers Disease
Luchsinger, J. A., & Mayeux, R. P. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362100 · Cited by 74
Plasma Amyloid-β Peptide Levels Correlate with Adipocyte Amyloid Precursor Protein Gene Expression in Obese Individuals
Lee, Y., Martin, J., Maple, R. L., Tharp, W. G., & Pratley, R. E. (2009) · Neuroendocrinology · doi:10.1159/000235555 · Cited by 69
Brain glucose metabolism in health, obesity, and cognitive decline-does insulin have anything to do with it? A narrative review
Rebelos, E., Rinne, J. O., Nuutila, P., & Ekblad, L. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071532 · Cited by 66
Cardiorespiratory Fitness in Early-stage Alzheimer Disease
Burns, J. M., Mayo, M. S., Anderson, H. S., Smith, H. J., & Donnelly, J. E. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815a9ddc · Cited by 65
Glucose metabolism and the risk of Alzheimer’s disease and dementia: a population-based 12 year follow-up study in 71-year-old men
Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Lannfelt, L., Berne, C., & Kilander, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1393-9 · Cited by 66
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 80
Evidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 64
Dementia Update 2005
Morris, J. C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000167923.56275.d8 · Cited by 61
Insulin resistance, diabetes and cognitive function: Consequences for preventative strategies
Bourdel‐Marchasson, I., Lapre, É., Laksir, H., & Puget, E. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.03.001 · Cited by 57
Alzheimer’s Disease and its Related Dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A Scoping Review
Lim, S., Mohaimin, S., Min, D., Roberts, T. R., Sohn, Y.-J., Wong, J., Sivanesathurai, R., Kwon, S. C., & Trinh‐Shevrin, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200509 · Cited by 49
Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance‐associated promotion of Alzheimer's disease β‐amyloid neuropathology
Zhao, Z., Ho, L., Wang, J., Qin, W., Festa, E. D., Mobbs, C., Hof, P., Rocher, A., Masur, S., Haroutunian, V., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-4359fje · Cited by 36
Fasting Insulin Levels and Cognitive Decline in Older Women without Diabetes
van Oijen, M., Okereke, O. I., Kang, J. H., Pollak, M. N., Hu, F. B., Hankinson, S. E., & Grodstein, F. (2008) · Neuroepidemiology · doi:10.1159/000126909 · Cited by 44
Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice
Griffith, C. M., Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X., Reagan, L. P., Strader, A. D., Rose, G. M., & Patrylo, P. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180707 · Cited by 44
Aging and Alzheimer’s Disease
LUPIEN, S. J., Lord, C., Sindi, S., Wilkinson, C. W., & Fiocco, A. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00097-8 · Cited by 42
Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model
Lanz, M., Janeiro, M. H., Milagro, F. I., Puerta, E., Ludwig, I. A., Pineda‐Lucena, A., Ramírez, M. J., & Solas, M. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111668 · Cited by 40
Diabetes: Vascular or Neurodegenerative
Launer, L. J. (2008) · Stroke · doi:10.1161/strokeaha.108.533075 · Cited by 36
Self-citation
Biomarkers in the path from cellular senescence to frailty
Zampino, M., Ferrucci, L., & Semba, R. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110750 · Cited by 35
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
López-Gambero, A. J., Rosell‐Valle, C., Vera, D. M., Navarro, J. A., Vargas, A., Rivera, P., Sanjuan, C., de Fonseca, F. R., & Suárez, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105365 · Cited by 37
Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study
Hooshmand, B., Rusanen, M., Ngandu, T., Leiviskä, J., Sindi, S., Arnim, C. A. F. V., Falkai, P., Soininen, H. S., Tuomilehto, J. O., & Kivipelto, M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.11.013 · Cited by 34
Cognition in Non-Demented Diabetic Older Adults
Nandipati, S., Luo, X., Schimming, C., Grossman, H. T., & Sano, M. C. (2012) · Current Aging Science · doi:10.2174/1874609811205020131 · Cited by 33
Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults
Byun, M. S., Kim, H. J., Yi, D., Choi, H. J., Baek, H., Lee, J. H., Choe, Y. M., Sohn, B. K., Lee, J., Lee, Y., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.004 · Cited by 31
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease
Reitz, C., Patel, B. N., Tang, M., Manly, J. J., Mayeux, R. P., & Luchsinger, J. A. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.030 · Cited by 30
Fasting Plasma Insulin, C-Peptide and Cognitive Change in Older Men without Diabetes: Results from the Physicians’ Health Study II
Okereke, O. I., Kurth, T., Pollak, M., Gaziano, J. M., & Grodstein, F. (2010) · Neuroepidemiology · doi:10.1159/000289351 · Cited by 30
Glycemic load and risk of Alzheimer's disease.
Luchsinger, J. A., Tang, M. ‐., & Mayeux, R. P. (2007) · PubMed · Cited by 29
A systematic review/meta‐analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian‐American in ADRD research
Zhu, Y., Park, S., Kolady, R., Zha, W., Ma, Y., Dias, A., McGuire, K., Hardi, A., Lin, S. C., Ismail, Z., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13820 · Cited by 26
Erythrocytes as Potential Link between Diabetes and Alzheimer’s Disease
Carelli‐Alinovi, C., & Misiti, F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00276 · Cited by 26
Relevance of Cardiovascular Risk Factors and Ischemic Cerebrovascular Disease to the Pathogenesis of Alzheimer Disease
White, L. R., & Launer, L. J. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00012 · Cited by 27
Self-citation
Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes
Okereke, O. I., Pollak, M., Hu, F. B., Hankinson, S. E., Selkoe, D. J., & Grodstein, F. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.01.002 · Cited by 26
Cognitive and affective functions in diabetic patients associated with diabetes‐related factors, white matter abnormality and aging
Hishikawa, N., Yamashita, T., Deguchi, K., Wada, J., Shikata, K., Makino, H., & Abe, K. (2014) · European Journal of Neurology · doi:10.1111/ene.12568 · Cited by 28
Fluid dynamics in aging-related dementias
Bah, T. M., Siler, D. A., Ibrahim, A. H., Cetas, J. S., & Alkayed, N. J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105986 · Cited by 26
Diabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24
Role of Peripheral and Central Insulin Resistance in Neuropsychiatric Disorders
Alagiakrishnan, K., & Halverson, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216607 · Cited by 25
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23
Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?
Hegde, V. K., Dhurandhar, N. V., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190808 · Cited by 22
The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
Ennis, G. E., Betthauser, T. J., Koscik, R. L., Chin, N. A., Christian, B. T., Asthana, S., Johnson, S. C., & Bendlin, B. B. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01180-2 · Cited by 26
Insulin resistance and cognitive performance in type 2 diabetes — The Maastricht study
Geijselaers, S. L. C., Sep, S. J. S., Schram, M. T., van Boxtel, M. P. J., Henry, R. M. A., Verhey, F. R. J., Kroon, A. A., Schaper, N. C., Dagnelie, P. C., Kallen, C., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.020 · Cited by 22
Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism
Zhou, Y., Zhao, Y., Xie, H., Wang, Y., Liu, L., & Yan, X. (2015) · Behavioral and Brain Functions · doi:10.1186/s12993-015-0069-5 · Cited by 21
A systematic review of existing peripheral biomarkers of cognitive aging: Is there enough evidence for biomarker proxies in behavioral modification interventions?
Fiocco, A. J., Krieger, L., D’Amico, D., Parrott, M. D., Laurin, D., Gaudreau, P., Greenwood, C., & Ferland, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.04.008 · Cited by 21
Low fasting serum insulin and dementia in nondiabetic women followed for 34 years
Mehlig, K., Lapidus, L., Thelle, D. S., Wærn, M., Zetterberg, H., Björkelund, C., Skoog, I. G., & Lissner, L. (2018) · Neurology · doi:10.1212/wnl.0000000000005911 · Cited by 19
Patterns of Compensation and Vulnerability in Normal Subjects at Risk of Alzheimer's Disease
López, O. L., Becker, J. T., & Kuller, L. H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129015 · Cited by 20
Insulin resistance is a risk factor for mild cognitive impairment in elderly adults with T2DM
Zhao, H., Wu, C., Zhang, X., Wang, L., Sun, J., & Zhuge, F. (2019) · Open Life Sciences · doi:10.1515/biol-2019-0029 · Cited by 19
Different treatment forms of type II diabetes and the risk of dementia in German health claims data
Buchmann, N., Fink, A., Tegeler, C., Demuth, I., Doblhammer, G., & Steinhagen‐Thiessen, E. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01332-7 · Cited by 17
Insulin-Degrading Enzyme Haplotypes Affect Insulin Levels but Not Dementia Risk
Marlowe, L., Peila, R., Benke, K. S., Hardy, J., White, L. R., Launer, L. J., & Myers, A. (2006) · Neurodegenerative Diseases · doi:10.1159/000097300 · Cited by 18
Self-citation
Lower insulin secretion is associated with hippocampal and parahippocampal gyrus atrophy in elderly patients with type 2 diabetes mellitus
Adachi, Y., Ota, K., Minami, I., Yamada, T., & Watanabe, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13554 · Cited by 17
Circulating biomarkers that predict incident dementia
Weinstein, G., & Seshadri, S. S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt235 · Cited by 16
The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study
West, N. A., Haan, M. N., & Morgenstern, H. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.06.005 · Cited by 16
The Association of Dementia With Upper Arm and Waist Circumference in Seven Low- and Middle-Income Countries: The 10/66 Cross-Sectional Surveys
Taylor, C. L., Albanese, E., & Stewart, R. J. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr244 · Cited by 17
Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer’s disease
López-Gambero, A. J., Pacheco-Sánchez, B., Rosell‐Valle, C., Vera, D. M., Navarro, J. A., Fernández‐Arjona, M. D. M., de Ceglia, M., Sanjuan, C., Simon, V., Cota, D., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112994 · Cited by 16
High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice
Gong, X., Liang, Z., Liu, W. D., Zhao, Y., Yang, Y., Wu, M., Shang, J., Xiao, Y., Mei, Y., Su, Q., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210628100812 · Cited by 14
Region-specific association between basal blood insulin and cerebral glucose metabolism in older adults
Byun, M. S., Kim, H. J., Yi, D., Choi, H. J., Baek, H., Lee, J. H., Choe, Y. M., Lee, S. H., Ko, K., Sohn, B. K., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101765 · Cited by 13
Mild Hypercholesterolemia, Normal Plasma Triglycerides, and Normal Glucose Levels Across Dementia Staging in Alzheimer’s Disease
Ramdane, S., & Daoudi‐Gueddah, D. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511414552 · Cited by 14
Factores de riesgo vascular y enfermedad de Alzheimer
Doña, P. J. R., Artigas, P. D. A., Guerra, M. L. S., & Monfort, C. A. (2009) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2008.12.004 · Cited by 15
Personality traits and cognitive function in old-adults with type-2 diabetes
Weinstein, G., Elran‐Barak, R., Beeri, M. S., & Ravona‐Springer, R. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1493720 · Cited by 9

Authors: Peila, R., Rodriguez, B. L., White, L. R., & Launer, L. J.
Affiliations: University of Hawaiʻi at Mānoa (US)
From the Laboratory of Epidemiology, Demography and Biometry (Drs. Peila and Launer), National Institute on Aging, National Institutes of Health, Bethesda, MD; Clinical Epidemiology and Geriatric Division (Drs. Rodriguez and White), Department of Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu; and Pacific Health Research Institute (Dr. White), Manoa, Honolulu, HI.
ORCID: Peila, Rita
White, Lon R.
Launer, Lenore J.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07-27
Volume: 63
Issue: 2
Pages: 228-233
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/01.wnl.0000129989.28404.9b
OpenAlex: W1981357357
Cited by: 152
References: 45
Citations by year: 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 1 · 2019: 14 · 2018: 11 · 2017: 7 · 2016: 9 · 2015: 4 · 2014: 6 · 2013: 6 · 2012: 8
FWCI: 3.94
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
National Institutes of Health (n01hc005102-027)
National Institute on Aging (N01‐AG‐4‐2149)
National Heart, Lung, and Blood Institute (N01-HC-O5102)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: fasting insulin, incident dementia, Japanese-American men, older men, insulin levels, dementia risk, Honolulu-Asia Aging Study, hyperinsulinemia, hypoinsulinemia
MeSH terms: Aged, Aged, 80 and over, Asian, Dementia, Diabetes Mellitus, Fasting, Hawaii, Humans, Hyperinsulinism, Insulin, Male, Prospective Studies, Risk Factors, Socioeconomic Factors, Cohort Studies, Confounding Factors, Epidemiologic, Proportional Hazards Models, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Fasting insulin and incident dementia in an elderly population of Japanese-American men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks